<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45364">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02091726</url>
  </required_header>
  <id_info>
    <org_study_id>Unicirc 003</org_study_id>
    <nct_id>NCT02091726</nct_id>
  </id_info>
  <brief_title>Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive</brief_title>
  <acronym>Unicirc003</acronym>
  <official_title>Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Simunye Primary Health Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Simunye Primary Health Care</source>
  <oversight_info>
    <authority>South Africa: Human Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a field trial of the Unicirc instrument to excise the foreskin, plus use of
      cyanoacrylate tissue adhesive to seal the wound.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Intraoperative bleeding</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Intraoperative bleeding requiring suture</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post operative bleeding</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Any bleeding (minor or requiring treatment) that occurs in the first 4 weeks post intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Post-op infection --minor (no treatment), moderate (requires antibiotics)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound dehiscence</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Wound separation caused by adhesive failure (minor --requires no treatment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any other adverse event</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Any other adverse event (pain, poor cosmetic result, other intraop or postop complication)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Male Circumcision</condition>
  <arm_group>
    <arm_group_label>Unicirc with tissue adhesive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Unicirc instrument plus cyanoacrylate tissue adhesive</intervention_name>
    <description>Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
    <arm_group_label>Unicirc with tissue adhesive</arm_group_label>
    <other_name>Unicirc</other_name>
    <other_name>Cyanoacrylate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Unicirc instrument</intervention_name>
    <arm_group_label>Unicirc with tissue adhesive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men at least 18 years of age

        Exclusion Criteria:

          -  Poor general health

          -  Anatomical abnormalities that would complicate circumcision

          -  Bleeding disorder

          -  Ongoing infection

          -  Cannot attend followup visits
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norman Goldstuck, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Obstetrics and Gynaecology, Tygerberg Hospital, Cape Town, South Africa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter S Millard, MD, PhD</last_name>
    <phone>+1-207-299-2131</phone>
    <email>pmillard@mac.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cyril Parker, MD</last_name>
    <email>management@simunyehealthcare.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Simunye Primary Healthcare</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril Parker, MD</last_name>
    </contact>
    <investigator>
      <last_name>Norman Goldstuck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 17, 2014</lastchanged_date>
  <firstreceived_date>March 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Simunye Primary Health Care</investigator_affiliation>
    <investigator_full_name>Peter Millard</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Circumcision</keyword>
  <keyword>HIV prevention</keyword>
  <keyword>Surgical device</keyword>
  <keyword>Cyanoacrylate</keyword>
  <keyword>Tissue Adhesive</keyword>
  <keyword>voluntary</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
